- Research
- 2022-2026 Research Strategy
- Open Clinical Trials
- Closed Clinical Trials
- What is a Clinical Trial?
- Why Participate in a Clinical Trial
- Remote Telehealth Pre-Screening Process
- Research Achievements
- Publications
- Research Development and Funding
- Participating Institutions
- International Collaboration
- BCT Trials & Projects Summary
- Translational Research
- Clinical Fellowship Program
- International Fellowship Support
- Annual Scientific Meeting
- Travel Grants and Awards
- About
- Our Impact
- Fundraise
- Donate
- Researcher Login
- Cart
CAMBRIA-2
Early Breast Cancer
The CAMBRIA-2 clinical trial aims to find out if giving a new endocrine therapy treatment known as a ‘selective estrogen receptor degrader’ (SERD) is better at stopping cancer from coming back…
Neo-N
Early Breast Cancer
The Neo-N clinical trial will investigate if using an immunotherapy drug together with chemotherapy, is safe and effective in treating breast cancer before surgery in women and men with early triple…
OLIO
Early Breast Cancer
The OLIO clinical trial aims to find out if adding the medications olaparib, or olaparib + durvalumab together, to standard chemotherapy given to pre-menopausal (18-45 year old) women with…
OPTIMA
Early Breast Cancer
The OPTIMA trial aims to find out if using a test called Prosigna can help make safe and accurate decisions about whether or not chemotherapy treatment is needed for participants with ER-positive,…
PROSPECTIVE
Early Breast Cancer
The PROSPECTIVE clinical trial aims to find out if surgery without radiotherapy will still be effective at stopping the cancer coming back while reducing the side effects and cost of usual treatment.
ACCESS TO CLINICAL TRIALS
WHAT IS A CLINICAL TRIAL?
Clinical trials are an important part of our health system and are necessary to find out if treatments are more effective than those currently accepted as the best available standard of care.
REMOTE TELEHEALTH PRE-SCREENING PROCESS
BCT is trialing a remote telehealth pre-screening process to broaden clinical trials access to regional and remote patients and improve clinical trial recruitment.
